SS
Sirigina Srinivasa Rao
About Sirigina Srinivasa Rao
Data last updated:
Sirigina Srinivasa Rao is a Director at Andhra Medi Pharma India Private Limited (since 2011). The company operates in Chemicals and Materials. Andhra Medi Pharma India Private Limited reported revenue of ₹76.02 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Andhra Medi Pharma India Private Limited U24233AP2009PTC065969 | Director | 15 Apr 2011 | 2009 | ₹76.02 Cr (FY 2025) | Active |
Board colleagues of Sirigina Srinivasa Rao
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anjana Chilakapati | 01924734 | Andhra Medi Pharma India Private Limited | Director |
| Burugupalli Srinivas | 03299494 | Andhra Medi Pharma India Private Limited | Director |
| Garikipati Kishore Kumar | 03305008 | Andhra Medi Pharma India Private Limited | Director |
| Kolathur Srinarayanan | 03306787 | Andhra Medi Pharma India Private Limited | Director |
| Rajeev Chilakapati | 01924690 | Andhra Medi Pharma India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sirigina Srinivasa Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sirigina Srinivasa Rao
Sirigina Srinivasa Rao currently holds 1 directorship: Andhra Medi Pharma India Private Limited (Director, since 15 Apr 2011, revenue ₹76.02 Cr (FY 2025)).
Sirigina Srinivasa Rao was first appointed on 15 Apr 2011 as Director at Andhra Medi Pharma India Private Limited.
The current boards of Sirigina Srinivasa Rao's companies include Anjana Chilakapati (Andhra Medi Pharma India Private Limited), Burugupalli Srinivas (Andhra Medi Pharma India Private Limited), Garikipati Kishore Kumar (Andhra Medi Pharma India Private Limited), Kolathur Srinarayanan (Andhra Medi Pharma India Private Limited), Rajeev Chilakapati (Andhra Medi Pharma India Private Limited).